TAG :UBI group

View More
UBI集團訊息
10102018
Mei Mei Hu | Democratizing Brain Health | Global Summit 2018 | Singularity University

Mei Mei Hu, CEO, United Neuroscience

UBI group
more
Mei Mei Hu | Democratizing Brain Health | Global Summit 2018 | Singularity University
View More
UBI集團訊息
25092018
Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018

Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018

UBI group
more
Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018
View More
UBI集團訊息
05092018
聯亞集團與長庚大學建教合作_作育英才提升臺灣生技產業競爭力

聯亞集團與長庚大學建教合作-107學年度暑期實習成果競賽於107年9月3日圓滿順利完成，實習生們皆有非常優異的傑出表現！

UBI group
more
聯亞集團與長庚大學建教合作_作育英才提升臺灣生技產業競爭力
View More
UBI集團訊息
22082018
聯生藥加碼台灣5年內將投資數十億擴產

聯生藥預計8/29停止興櫃買賣，轉往海外掛牌！董事王長怡表示，根留台灣信念不變，將持續投資台灣

UBI group
more
聯生藥加碼台灣5年內將投資數十億擴產
View More
UBI集團訊息
14082018
聯合生物製藥為長期發展策略，董事會決議終止櫃檯買賣(問答集更新&新聞稿)

更新問答集&新聞稿

UBI group
more
聯合生物製藥為長期發展策略，董事會決議終止櫃檯買賣(問答集更新&新聞稿)
View More
UBI集團訊息
20072018
聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎新創技術銅獎

開發中針對治療過敏症的創新抗IgE單株抗體UB-221研發成果備受肯定，榮獲2018年台北生技獎新創技術獎之「銅獎」。

UBI group

創新型IgE單株抗體UB-221
more
聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎新創技術銅獎
View More
UBI集團訊息
12062018
聯生藥抗IgE 抗體新藥UB-221 將進入人體臨床一期試驗

向台灣食品藥物管理署提交創新抗IgE 抗體新藥UB-221 之人體臨床一期試驗申請。

UBI group

創新型IgE單株抗體UB-221
more
聯生藥抗IgE 抗體新藥UB-221 將進入人體臨床一期試驗
View More
UBI集團訊息
01062018
聯生藥進軍陸抗體藥市場

為拓展中國龐大且剛起步的單株抗體藥物市場，並作為前進國際的第一步，聯生藥分別於上海與揚州成立兩家子公司

UBI group

王長怡博士
more
聯生藥進軍陸抗體藥市場
View More
UBI集團訊息
28042018
United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City

United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City

UBI group
more
United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City
View More
UBI集團訊息
25042018
美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士受邀在2018揚州生物醫藥論壇中專題演講

王長怡博士受邀於25日在揚州月畔灣酒店由揚州國家高新技術產業開發區舉辦的「2018揚州生物醫藥論壇」中給予專題演講。

UBI group

王長怡博士
more
美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士受邀在2018揚州生物醫藥論壇中專題演講
View More
UBI集團訊息
11042018
United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease

Candidates Generated with United Neuroscience Endobody Technology Will be Tested at the Center for Alzheimer’s and Neurodegenerative Diseases

UBI group

阿茲海默症治療型疫苗UB-311
more
United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease
View More
UBI集團訊息
23032018
United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson’s Disease

Research Collaboration Focuses on United Neuroscience “Endobody" Technology Directed Against Pathogenic Forms of α-Synuclein Protein

UBI group
more
United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson’s Disease

我們有話要説 (一)：請各界持續支持各式國產疫苗的開發、厚植國力

我們有話要說 (二)：病毒不斷突變也不怕！聯亞生技廣譜新冠疫苗可協助解決病毒變異及疫苗頻繁接種的安全與有效性！

我們有話要說 (三)：良好的保護力絕不能只看中和抗體！全球科學界大聲疾呼正視T細胞免疫記憶能力之重要性 –強力T細胞免疫才能提供免於感染各種變異病毒株的廣譜保護力–

我們有話要說(四)：聯亞生技UB-612新冠疫苗追加劑試驗數據展現強效且廣譜的的B細胞和T細胞免疫能力; 期盼政府支持UB-612加速審查，共同為國家與人民福祉創造多贏

Mei Mei Hu | Democratizing Brain Health | Global Summit 2018 | Singularity University

Meimei Hu, CEO of United Neuroscience, is to participate in Fortune Most Powerful Women Summit 2018

聯亞集團與長庚大學建教合作_作育英才 提升臺灣生技產業競爭力

聯生藥加碼台灣5年內將投資數十億擴產

聯合生物製藥為長期發展策略，董事會決議終止櫃檯買賣(問答集更新&新聞稿)

聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎 新創技術銅獎

聯生藥抗IgE 抗體新藥UB-221 將進入人體臨床一期試驗

聯生藥 進軍陸抗體藥市場

United Neuroscience to Present at the Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fourth International ‘Unite To Cure’ Conference in Vatican City

美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士 受邀在2018揚州生物醫藥論壇中專題演講

United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease

United Neuroscience Signs Collaboration Agreement with French National Center for Scientific Research (CNRS) Laboratory to Target Protein Associated with Parkinson’s Disease

聯亞集團與長庚大學建教合作_作育英才提升臺灣生技產業競爭力

聯生藥治療氣喘和過敏單株抗體UB-221 榮獲2018臺北生技獎新創技術銅獎

聯生藥進軍陸抗體藥市場

美國UBI集團暨聯生藥與聯亞藥董事長王長怡博士受邀在2018揚州生物醫藥論壇中專題演講